Catalyst Pharmaceuticals Ratios (2010-2026) | CPRX

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Ratios	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Profitability
Gross Margin (Quarter)	87.50%	85.23%	80.82%	86.33%	85.61%	83.12%	81.57%	88.35%	87.90%	86.20%	85.70%	87.29%	87.45%	85.02%	84.74%	87.33%	85.94%	84.73%	82.91%	90.31%
EBT Margin (Quarter)	43.72%	39.14%	33.45%	40.52%	53.18%	45.43%	54.33%	43.71%	48.72%	-37.03%	42.24%	29.53%	45.46%	44.45%	52.31%	50.41%	47.28%	47.87%	47.11%	56.38%
EBIT Margin (Quarter)	43.55%	38.95%	33.26%	40.30%	53.79%	43.85%	50.70%	41.71%	46.90%	-36.21%	37.71%	27.54%	44.21%	39.56%	44.31%	44.81%	45.24%	44.66%	40.52%	49.02%
EBITDA Margin (Quarter)	33.52%	28.66%	24.08%	30.02%	41.31%	40.02%	41.91%	34.62%	37.93%	-29.96%	31.51%	23.61%	33.24%	34.10%	39.49%	40.06%	35.59%	35.55%	34.53%	42.67%
Operating Margin (Quarter)	43.55%	38.95%	33.26%	40.30%	53.79%	43.85%	50.70%	41.71%	46.90%	-36.21%	37.71%	27.54%	44.21%	39.56%	44.31%	44.81%	45.24%	44.66%	40.52%	49.02%
Net Margin (Quarter)	33.50%	28.73%	24.30%	30.73%	40.70%	39.74%	56.38%	34.64%	37.92%	-29.96%	15.41%	23.63%	33.24%	34.10%	32.78%	40.12%	35.55%	35.57%	30.10%	42.66%
FCF Margin (Quarter)	43.10%	60.19%	49.95%	19.68%	49.31%	72.15%	65.96%	14.05%	30.88%	43.88%	50.25%	32.21%	52.26%	56.42%	49.91%	42.46%	48.63%	21.86%	29.39%	39.87%
Efficiency
Inventory Average (Quarter)	5.74M	7.02M	7.41M	7.85M	7.84M	7.49M	6.97M	8.57M	10.54M	9.89M	12.34M	17.80M	18.98M	19.02M	19.78M	19.66M	19.21M	23.34M	32.60M	36.05M
Assets Average (Quarter)	203.17M	216.19M	230.52M	242.38M	257.14M	300.21M	354.37M	391.43M	425.56M	428.55M	441.66M	558.39M	676.52M	739.18M	811.71M	880.14M	940.39M	1,011.76M	1,077.79M	1,125.79M
Equity Average (Quarter)	183.80M	193.80M	202.75M	213.53M	230.66M	255.57M	285.23M	317.04M	354.48M	361.92M	368.21M	474.65M	585.03M	634.80M	694.29M	760.96M	825.15M	888.14M	937.26M	983.48M
Invested Capital (Quarter)	188.94M	198.66M	206.83M	220.22M	241.09M	270.04M	300.42M	333.66M	375.29M	348.55M	387.88M	561.41M	608.65M	660.94M	727.63M	794.28M	856.03M	920.25M	954.27M	1,012.70M
Asset Utilization Ratio (Quarter)	0.62	0.62	0.61	0.63	0.66	0.64	0.60	0.66	0.71	0.81	0.90	0.74	0.64	0.62	0.61	0.61	0.59	0.57	0.55	0.53
Leverage & Solvency
Equity Ratio (Quarter)	0.90	0.89	0.87	0.89	0.90	0.81	0.80	0.82	0.85	0.84	0.83	0.87	0.86	0.86	0.85	0.87	0.88	0.88	0.86	0.88
Valuation
Enterprise Value (Quarter)	-155.28M	-174.79M	-191.27M	-197.80M	-220.79M	-256.06M	-298.39M	-148.25M	-178.79M	-120.97M	-137.64M	-310.41M	-375.69M	-442.33M	-517.55M	-580.66M	-652.80M	-689.89M	-709.17M	-755.86M
Return Ratios
Return on Sales (Quarter)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.01%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Capital Employed (Quarter)	24.57%	24.68%	25.75%	27.32%	30.97%	32.79%	34.31%	35.88%	37.05%	20.48%	23.75%	16.36%	14.70%	27.45%	28.24%	30.11%	29.42%	29.31%	27.70%	26.94%
Return on Invested Capital (Quarter)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Assets (Quarter)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Equity (Quarter)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Research Tools

Catalyst Pharmaceuticals Ratios (2010-2026) | CPRX

Create an account

Sign In

Reset Password